Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07207564 · ClinicalTrials.gov registry record
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
A clinical trial of Breast Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 4,500
- Enrollment target
- 2
- Study locations
NCT07207564 is a study of Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 4,500 participants, above the 728-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (518% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07207564, a study of Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 4,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (2)
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,500 participants |
| Start Date | 2025-08-28 |
| Est. Completion | 2030-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07207564
The ClinicalTrials.gov registry entry for NCT07207564 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 728-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (518% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07207564 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07207564 about?
NCT07207564 is a clinical study titled "Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk". The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
What is the current status of trial NCT07207564?
This trial is currently recruiting. The enrollment target is 4,500 participants. The study started on 2025-08-28. Estimated completion is 2030-06-30.
What conditions does trial NCT07207564 study?
This clinical trial studies the following conditions: Breast Carcinoma.
What interventions are being tested in trial NCT07207564?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07207564?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07207564 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.